Lite Strategy, Inc.(LITS)

Biotechnology · San Diego, CA

$1.41+0.01 (+0.36%)

Delayed quote: Oct 6, 2026, 2:23 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T18:27:20.128Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:27:20.128Z.

Quote observation: 2026-10-06T18:23:52.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 47,805,406
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 5,706,000
TTM free cash flow · period ending 2026-06-30: -9,121,000

FMP input reference: 0dc40ddd6b0c815ea8fb06d6c0f10798674f4babd9a38c246e46e89e51900236

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LITS EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

LITS Competitors' EV/FCF Ratio

LITS

Lite Strategy, Inc.

Current

Market Cap

$47.81M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TIL

Instil Bio, Inc.

vs LITS

Market Cap

$47.41M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs LITS

Market Cap

$48.77M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TELA

TELA Bio, Inc.

vs LITS

Market Cap

$49.44M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

POCI

Precision Optics Corporation, Inc.

vs LITS

Market Cap

$49.47M

EV/FCF Ratio

N/A

TTM Avg

104.90x

3Y Avg

104.90x

5Y Avg

95.87x

APLM

Apollomics, Inc.

vs LITS

Market Cap

$49.52M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRTS

Sensus Healthcare, Inc.

vs LITS

Market Cap

$49.55M

EV/FCF Ratio

N/A

TTM Avg

41.95x

3Y Avg

42.62x

5Y Avg

49.44x

INMB

INmune Bio, Inc.

vs LITS

Market Cap

$49.45M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBOT

Microbot Medical Inc.

vs LITS

Market Cap

$49.44M

EV/FCF Ratio

N/A

TTM Avg

12.79x

3Y Avg

13.79x

5Y Avg

13.79x

COCH

Envoy Medical, Inc.

vs LITS

Market Cap

$50.64M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Lite Strategy, Inc. (LITS)	$47.81M	N/A	N/A	N/A	N/A
Instil Bio, Inc. (TIL)vs ›	$47.41M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$48.77M	N/A	N/A	N/A	N/A
TELA Bio, Inc. (TELA)vs ›	$49.44M	N/A	N/A	N/A	N/A
Precision Optics Corporation, Inc. (POCI)vs ›	$49.47M	N/A	104.90x	104.90x	95.87x
Apollomics, Inc. (APLM)vs ›	$49.52M	N/A	N/A	N/A	N/A
Sensus Healthcare, Inc. (SRTS)vs ›	$49.55M	N/A	41.95x	42.62x	49.44x
INmune Bio, Inc. (INMB)vs ›	$49.45M	N/A	N/A	N/A	N/A
Microbot Medical Inc. (MBOT)vs ›	$49.44M	N/A	12.79x	13.79x	13.79x
Envoy Medical, Inc. (COCH)vs ›	$50.64M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

LITS EV/FCF Ratio Metrics

LITS Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics